Bipolar Disorder

In what 5 ways can anxiety present in bipolar disorder?

A case report and literature review of intrathecal methotrexate-induced mania.

Although supported by basic science, it’s still a sea change to think that diet can treat depression. Some research puts that idea to the test.

If approved by the FDA, this treatment would be the first therapy for treating depressive episodes in both bipolar I and II disorder in 2 different forms.

When dealing with a serious mental illness, speaking out and sharing common experiences can help healing.

As we learn about the effect of COVID-19 on patients with bipolar and other psychiatric disorders, clinicians should be prepared to ask questions to uncover new syndromic behaviors.

A new test screens for bipolar disorder with respectable accuracy

Are there differences in the clinical course of bipolar I and bipolar II disorder with and without comorbid alcohol use disorder?

When concern for a patient is not so severe that a clinician feels compelled to call the police, there are options.

Although clinicians and patients may wish otherwise, the comorbidity of ADHD and bipolar disorder needs to be considered.

What are they key differences between ADHD and bipolar disorder? How can they be identified?

For many patients, the most painful part of bipolar disorder is the loss of control over their own mind.

The psychiatric prescribing clinician may be called upon to treat pain comorbid with bipolar disorder.

David Osser, MD, comments on the low priority of valproate for treating patients with bipolar disorder.

Is valproic acid dismissed out of hand? Three doctors discuss its potential as a treatment.

Oxcarbazepine might be considered for patients who you want to treat with carbamazepine for mania (as monotherapy or adjunct) but for whom it would be unsafe or who have been unable to tolerate it.

The risk of “false positive” screening in primary care settings is reduced by a thorough clinical evaluation.

Bipolar disorder screening scales have modest sensitivity; thus, a negative result does not preclude a clinical evaluation.

Alkermes plc’s new drug, ALKS 3831, pending FDA approval, could be helpful in the treatment of patients with schizophrenia or bipolar I disorder.

There are many reasons symptoms worsen in younger patients who are prescribed antidepressants. Five possible scenarios are discussed in this podcast.

Chris Aiken, MD, and Kellie Newsome, PMH-NP, discuss best practices for dosing quetiapine for the treatment of bipolar disorder.

Chris Aiken, MD, and Kellie Newsome, PMH-NP, discuss how to dose lithium for the treatment of bipolar disorder.

Which one rises to the top of your list? More in this podcast.

There are some off-label proposed uses for topiramate in comorbidities that are common in patients with bipolar disorder. What does the evidence say?